# FDA Inspection 1060260 - Merck Sante s.a.s - June 14, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/merck-sante-sas/1ecf2a10-554d-40d1-873c-05b90f8e5a09
Source feed: FDA_Inspections

> FDA Inspection 1060260 for Merck Sante s.a.s on June 14, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1060260
- Company Name: Merck Sante s.a.s
- Inspection Date: 2018-06-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1270283 - 2024-10-25](https://www.globalkeysolutions.net/records/fda_inspections/merck-sante-sas/aff438ee-8e3e-40ec-8880-000de84f988c)
- [FDA Inspection 1270283 - 2024-10-25](https://www.globalkeysolutions.net/records/fda_inspections/merck-sante-sas/350adabc-9bba-4445-bc3f-f37b935961e2)
- [FDA Inspection 990190 - 2016-06-21](https://www.globalkeysolutions.net/records/fda_inspections/merck-sante-sas/117dec16-c4c0-42ea-a74c-f2083f3a6214)
- [FDA Inspection 842828 - 2013-06-17](https://www.globalkeysolutions.net/records/fda_inspections/merck-sante-sas/ce77d43f-85d6-4360-8470-440756a760bb)

Company: https://www.globalkeysolutions.net/companies/merck-sante-sas/71d1631f-93a6-4a97-b401-d18d7de86fc1

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c